Alimentary System |
Liver |
Centrilobular |
Vehicle Control |
5 |
31 |
31 |
18 |
1 |
Vacuolization Cytoplasmic |
Minimal |
Terminal Sacrifice |
Alimentary System |
Liver |
Centrilobular |
Vehicle Control |
5 |
32 |
32 |
18 |
1 |
Vacuolization Cytoplasmic |
Minimal |
Terminal Sacrifice |
Alimentary System |
Liver |
Centrilobular |
Vehicle Control |
5 |
33 |
33 |
18 |
1 |
Vacuolization Cytoplasmic |
Minimal |
Terminal Sacrifice |
Alimentary System |
Liver |
Centrilobular |
Vehicle Control |
5 |
34 |
34 |
18 |
1 |
Vacuolization Cytoplasmic |
Minimal |
Terminal Sacrifice |
Alimentary System |
Liver |
Centrilobular |
Vehicle Control |
5 |
35 |
35 |
18 |
1 |
Vacuolization Cytoplasmic |
Minimal |
Terminal Sacrifice |
Alimentary System |
Liver |
Centrilobular |
31.25 MG/KG |
5 |
36 |
36 |
18 |
1 |
Vacuolization Cytoplasmic |
Minimal |
Terminal Sacrifice |
Alimentary System |
Liver |
Centrilobular |
31.25 MG/KG |
5 |
37 |
37 |
18 |
1 |
Vacuolization Cytoplasmic |
Minimal |
Terminal Sacrifice |
Alimentary System |
Liver |
Centrilobular |
31.25 MG/KG |
5 |
38 |
38 |
18 |
1 |
Vacuolization Cytoplasmic |
Minimal |
Terminal Sacrifice |
Alimentary System |
Liver |
Centrilobular |
31.25 MG/KG |
5 |
39 |
39 |
18 |
1 |
Vacuolization Cytoplasmic |
Minimal |
Terminal Sacrifice |
Alimentary System |
Liver |
Centrilobular |
31.25 MG/KG |
5 |
40 |
40 |
18 |
1 |
Vacuolization Cytoplasmic |
Minimal |
Terminal Sacrifice |
Alimentary System |
Liver |
Centrilobular |
62.5 MG/KG |
5 |
41 |
41 |
18 |
1 |
Vacuolization Cytoplasmic |
Mild |
Terminal Sacrifice |
Alimentary System |
Liver |
Centrilobular |
62.5 MG/KG |
5 |
42 |
42 |
18 |
1 |
Vacuolization Cytoplasmic |
Mild |
Terminal Sacrifice |
Alimentary System |
Liver |
Centrilobular |
62.5 MG/KG |
5 |
43 |
43 |
18 |
1 |
Vacuolization Cytoplasmic |
Mild |
Terminal Sacrifice |
Alimentary System |
Liver |
Centrilobular |
62.5 MG/KG |
5 |
44 |
44 |
18 |
1 |
Vacuolization Cytoplasmic |
Mild |
Terminal Sacrifice |
Alimentary System |
Liver |
Centrilobular |
62.5 MG/KG |
5 |
45 |
45 |
18 |
1 |
Vacuolization Cytoplasmic |
Mild |
Terminal Sacrifice |
Alimentary System |
Liver |
Centrilobular |
125 MG/KG |
5 |
46 |
46 |
18 |
1 |
Vacuolization Cytoplasmic |
Mild |
Terminal Sacrifice |
Alimentary System |
Liver |
Centrilobular |
125 MG/KG |
5 |
47 |
47 |
18 |
1 |
Vacuolization Cytoplasmic |
Mild |
Terminal Sacrifice |
Alimentary System |
Liver |
Centrilobular |
125 MG/KG |
5 |
48 |
48 |
18 |
1 |
Vacuolization Cytoplasmic |
Mild |
Terminal Sacrifice |
Alimentary System |
Liver |
Centrilobular |
125 MG/KG |
5 |
49 |
49 |
18 |
1 |
Vacuolization Cytoplasmic |
Mild |
Terminal Sacrifice |
Alimentary System |
Liver |
Centrilobular |
125 MG/KG |
5 |
50 |
50 |
18 |
1 |
Vacuolization Cytoplasmic |
Mild |
Terminal Sacrifice |
Alimentary System |
Liver |
Centrilobular |
250 MG/KG |
5 |
51 |
51 |
18 |
1 |
Vacuolization Cytoplasmic |
Mild |
Terminal Sacrifice |
Alimentary System |
Liver |
Centrilobular |
250 MG/KG |
5 |
52 |
52 |
18 |
1 |
Vacuolization Cytoplasmic |
Moderate |
Terminal Sacrifice |
Alimentary System |
Liver |
Centrilobular |
250 MG/KG |
5 |
53 |
53 |
18 |
1 |
Vacuolization Cytoplasmic |
Mild |
Terminal Sacrifice |
Alimentary System |
Liver |
Centrilobular |
250 MG/KG |
5 |
54 |
54 |
18 |
1 |
Vacuolization Cytoplasmic |
Moderate |
Terminal Sacrifice |
Alimentary System |
Liver |
Centrilobular |
250 MG/KG |
5 |
55 |
55 |
18 |
1 |
Vacuolization Cytoplasmic |
Mild |
Terminal Sacrifice |
Alimentary System |
Liver |
Centrilobular |
500 MG/KG |
5 |
56 |
56 |
18 |
1 |
Vacuolization Cytoplasmic |
Moderate |
Terminal Sacrifice |
Alimentary System |
Liver |
Centrilobular |
500 MG/KG |
5 |
57 |
57 |
18 |
1 |
Vacuolization Cytoplasmic |
Moderate |
Terminal Sacrifice |
Alimentary System |
Liver |
Centrilobular |
500 MG/KG |
5 |
58 |
58 |
18 |
1 |
Vacuolization Cytoplasmic |
Moderate |
Terminal Sacrifice |
Alimentary System |
Liver |
Centrilobular |
500 MG/KG |
5 |
59 |
59 |
18 |
1 |
Vacuolization Cytoplasmic |
Moderate |
Terminal Sacrifice |
Alimentary System |
Liver |
Centrilobular |
500 MG/KG |
5 |
60 |
60 |
18 |
1 |
Vacuolization Cytoplasmic |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
Control |
500 MG/KG |
5 |
58 |
58 |
18 |
1 |
Hyperkeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Control, Epidermis |
500 MG/KG |
5 |
58 |
58 |
18 |
1 |
Hyperplasia |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
125 MG/KG |
5 |
46 |
46 |
18 |
1 |
Fibrosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
125 MG/KG |
5 |
48 |
48 |
18 |
1 |
Fibrosis |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
125 MG/KG |
5 |
49 |
49 |
18 |
1 |
Fibrosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
125 MG/KG |
5 |
50 |
50 |
18 |
1 |
Fibrosis |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
250 MG/KG |
5 |
51 |
51 |
18 |
1 |
Fibrosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
250 MG/KG |
5 |
52 |
52 |
18 |
1 |
Fibrosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
250 MG/KG |
5 |
53 |
53 |
18 |
1 |
Fibrosis |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
250 MG/KG |
5 |
54 |
54 |
18 |
1 |
Fibrosis |
Marked |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
250 MG/KG |
5 |
55 |
55 |
18 |
1 |
Fibrosis |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
500 MG/KG |
5 |
56 |
56 |
18 |
1 |
Fibrosis |
Marked |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
500 MG/KG |
5 |
57 |
57 |
18 |
1 |
Fibrosis |
Marked |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
500 MG/KG |
5 |
58 |
58 |
18 |
1 |
Fibrosis |
Marked |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
500 MG/KG |
5 |
59 |
59 |
18 |
1 |
Fibrosis |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
500 MG/KG |
5 |
60 |
60 |
18 |
1 |
Fibrosis |
Marked |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
62.5 MG/KG |
5 |
42 |
42 |
18 |
1 |
Inflammation |
Minimal, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
62.5 MG/KG |
5 |
43 |
43 |
18 |
1 |
Inflammation |
Minimal, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
125 MG/KG |
5 |
46 |
46 |
18 |
1 |
Inflammation |
Mild, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
125 MG/KG |
5 |
47 |
47 |
18 |
1 |
Inflammation |
Minimal, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
125 MG/KG |
5 |
48 |
48 |
18 |
1 |
Inflammation |
Minimal, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
125 MG/KG |
5 |
49 |
49 |
18 |
1 |
Inflammation |
Mild, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
125 MG/KG |
5 |
50 |
50 |
18 |
1 |
Inflammation |
Minimal, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
250 MG/KG |
5 |
51 |
51 |
18 |
1 |
Inflammation |
Mild, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
250 MG/KG |
5 |
52 |
52 |
18 |
1 |
Inflammation |
Mild, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
250 MG/KG |
5 |
53 |
53 |
18 |
1 |
Inflammation |
Moderate, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
250 MG/KG |
5 |
54 |
54 |
18 |
1 |
Inflammation |
Moderate, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
250 MG/KG |
5 |
55 |
55 |
18 |
1 |
Inflammation |
Moderate, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
500 MG/KG |
5 |
56 |
56 |
18 |
1 |
Inflammation |
Marked, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
500 MG/KG |
5 |
57 |
57 |
18 |
1 |
Inflammation |
Marked, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
500 MG/KG |
5 |
58 |
58 |
18 |
1 |
Inflammation |
Marked, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
500 MG/KG |
5 |
59 |
59 |
18 |
1 |
Inflammation |
Marked, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
500 MG/KG |
5 |
60 |
60 |
18 |
1 |
Inflammation |
Marked, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
62.5 MG/KG |
5 |
41 |
41 |
18 |
1 |
Hyperplasia |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
62.5 MG/KG |
5 |
42 |
42 |
18 |
1 |
Hyperplasia |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
62.5 MG/KG |
5 |
43 |
43 |
18 |
1 |
Hyperplasia |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
62.5 MG/KG |
5 |
44 |
44 |
18 |
1 |
Hyperplasia |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
62.5 MG/KG |
5 |
45 |
45 |
18 |
1 |
Hyperplasia |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
125 MG/KG |
5 |
46 |
46 |
18 |
1 |
Hyperplasia |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
125 MG/KG |
5 |
47 |
47 |
18 |
1 |
Hyperplasia |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
125 MG/KG |
5 |
48 |
48 |
18 |
1 |
Hyperplasia |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
125 MG/KG |
5 |
49 |
49 |
18 |
1 |
Hyperplasia |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
125 MG/KG |
5 |
50 |
50 |
18 |
1 |
Hyperplasia |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
250 MG/KG |
5 |
51 |
51 |
18 |
1 |
Hyperplasia |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
250 MG/KG |
5 |
52 |
52 |
18 |
1 |
Hyperplasia |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
250 MG/KG |
5 |
53 |
53 |
18 |
1 |
Hyperplasia |
Marked |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
250 MG/KG |
5 |
54 |
54 |
18 |
1 |
Hyperplasia |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
250 MG/KG |
5 |
55 |
55 |
18 |
1 |
Hyperplasia |
Marked |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
500 MG/KG |
5 |
56 |
56 |
18 |
1 |
Hyperplasia |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
500 MG/KG |
5 |
57 |
57 |
18 |
1 |
Hyperplasia |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
500 MG/KG |
5 |
58 |
58 |
18 |
1 |
Hyperplasia |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
500 MG/KG |
5 |
59 |
59 |
18 |
1 |
Hyperplasia |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
125 MG/KG |
5 |
49 |
49 |
18 |
1 |
Inflammation |
Minimal, Suppurative |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
250 MG/KG |
5 |
52 |
52 |
18 |
1 |
Inflammation |
Moderate, Suppurative |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
250 MG/KG |
5 |
54 |
54 |
18 |
1 |
Inflammation |
Moderate, Suppurative |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
250 MG/KG |
5 |
55 |
55 |
18 |
1 |
Inflammation |
Minimal, Suppurative |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
500 MG/KG |
5 |
56 |
56 |
18 |
1 |
Inflammation |
Marked, Suppurative |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
500 MG/KG |
5 |
57 |
57 |
18 |
1 |
Inflammation |
Marked, Suppurative |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
500 MG/KG |
5 |
58 |
58 |
18 |
1 |
Inflammation |
Marked, Suppurative |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
500 MG/KG |
5 |
59 |
59 |
18 |
1 |
Inflammation |
Marked, Suppurative |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
500 MG/KG |
5 |
60 |
60 |
18 |
1 |
Inflammation |
Marked, Suppurative |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
62.5 MG/KG |
5 |
44 |
44 |
18 |
1 |
Necrosis |
Minimal, Focal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
125 MG/KG |
5 |
47 |
47 |
18 |
1 |
Necrosis |
Minimal, Focal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
125 MG/KG |
5 |
48 |
48 |
18 |
1 |
Necrosis |
Minimal, Focal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
125 MG/KG |
5 |
49 |
49 |
18 |
1 |
Necrosis |
Minimal, Focal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
250 MG/KG |
5 |
51 |
51 |
18 |
1 |
Necrosis |
Minimal, Focal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
250 MG/KG |
5 |
52 |
52 |
18 |
1 |
Necrosis |
Mild, Focal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
250 MG/KG |
5 |
54 |
54 |
18 |
1 |
Necrosis |
Minimal, Focal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
250 MG/KG |
5 |
55 |
55 |
18 |
1 |
Necrosis |
Moderate, Focal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
500 MG/KG |
5 |
58 |
58 |
18 |
1 |
Necrosis |
Marked, Focal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
500 MG/KG |
5 |
59 |
59 |
18 |
1 |
Necrosis |
Moderate, Focal |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
62.5 MG/KG |
5 |
41 |
41 |
18 |
1 |
Hyperkeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
62.5 MG/KG |
5 |
42 |
42 |
18 |
1 |
Hyperkeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
62.5 MG/KG |
5 |
43 |
43 |
18 |
1 |
Hyperkeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
62.5 MG/KG |
5 |
44 |
44 |
18 |
1 |
Hyperkeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
62.5 MG/KG |
5 |
45 |
45 |
18 |
1 |
Hyperkeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
125 MG/KG |
5 |
46 |
46 |
18 |
1 |
Hyperkeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
125 MG/KG |
5 |
47 |
47 |
18 |
1 |
Hyperkeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
125 MG/KG |
5 |
48 |
48 |
18 |
1 |
Hyperkeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
125 MG/KG |
5 |
49 |
49 |
18 |
1 |
Hyperkeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
125 MG/KG |
5 |
50 |
50 |
18 |
1 |
Hyperkeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
250 MG/KG |
5 |
51 |
51 |
18 |
1 |
Hyperkeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
250 MG/KG |
5 |
52 |
52 |
18 |
1 |
Hyperkeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
250 MG/KG |
5 |
53 |
53 |
18 |
1 |
Hyperkeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
250 MG/KG |
5 |
54 |
54 |
18 |
1 |
Hyperkeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
250 MG/KG |
5 |
55 |
55 |
18 |
1 |
Hyperkeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
500 MG/KG |
5 |
56 |
56 |
18 |
1 |
Hyperkeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
500 MG/KG |
5 |
57 |
57 |
18 |
1 |
Hyperkeratosis |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
500 MG/KG |
5 |
58 |
58 |
18 |
1 |
Hyperkeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
500 MG/KG |
5 |
59 |
59 |
18 |
1 |
Hyperkeratosis |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
125 MG/KG |
5 |
46 |
46 |
18 |
1 |
Parakeratosis |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
125 MG/KG |
5 |
47 |
47 |
18 |
1 |
Parakeratosis |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
125 MG/KG |
5 |
48 |
48 |
18 |
1 |
Parakeratosis |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
125 MG/KG |
5 |
49 |
49 |
18 |
1 |
Parakeratosis |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
250 MG/KG |
5 |
51 |
51 |
18 |
1 |
Parakeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
250 MG/KG |
5 |
52 |
52 |
18 |
1 |
Parakeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
250 MG/KG |
5 |
53 |
53 |
18 |
1 |
Parakeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
250 MG/KG |
5 |
54 |
54 |
18 |
1 |
Parakeratosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
250 MG/KG |
5 |
55 |
55 |
18 |
1 |
Parakeratosis |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
500 MG/KG |
5 |
57 |
57 |
18 |
1 |
Parakeratosis |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
125 MG/KG |
5 |
48 |
48 |
18 |
1 |
Ulcer |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
250 MG/KG |
5 |
51 |
51 |
18 |
1 |
Ulcer |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
250 MG/KG |
5 |
52 |
52 |
18 |
1 |
Ulcer |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
250 MG/KG |
5 |
54 |
54 |
18 |
1 |
Ulcer |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
250 MG/KG |
5 |
55 |
55 |
18 |
1 |
Ulcer |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
500 MG/KG |
5 |
56 |
56 |
18 |
1 |
Ulcer |
Marked |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
500 MG/KG |
5 |
57 |
57 |
18 |
1 |
Ulcer |
Marked |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
500 MG/KG |
5 |
58 |
58 |
18 |
1 |
Ulcer |
Marked |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
500 MG/KG |
5 |
59 |
59 |
18 |
1 |
Ulcer |
Marked |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
500 MG/KG |
5 |
60 |
60 |
18 |
1 |
Ulcer |
Marked |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Subcut Tiss |
250 MG/KG |
5 |
51 |
51 |
18 |
1 |
Fibrosis |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Subcut Tiss |
250 MG/KG |
5 |
52 |
52 |
18 |
1 |
Fibrosis |
Minimal |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Subcut Tiss |
250 MG/KG |
5 |
53 |
53 |
18 |
1 |
Fibrosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Subcut Tiss |
250 MG/KG |
5 |
54 |
54 |
18 |
1 |
Fibrosis |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Subcut Tiss |
250 MG/KG |
5 |
55 |
55 |
18 |
1 |
Fibrosis |
Mild |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Subcut Tiss |
500 MG/KG |
5 |
56 |
56 |
18 |
1 |
Fibrosis |
Marked |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Subcut Tiss |
500 MG/KG |
5 |
57 |
57 |
18 |
1 |
Fibrosis |
Marked |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Subcut Tiss |
500 MG/KG |
5 |
58 |
58 |
18 |
1 |
Fibrosis |
Marked |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Subcut Tiss |
500 MG/KG |
5 |
59 |
59 |
18 |
1 |
Fibrosis |
Moderate |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Subcut Tiss |
500 MG/KG |
5 |
60 |
60 |
18 |
1 |
Fibrosis |
Marked |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Subcut Tiss |
250 MG/KG |
5 |
51 |
51 |
18 |
1 |
Inflammation |
Minimal, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Subcut Tiss |
250 MG/KG |
5 |
52 |
52 |
18 |
1 |
Inflammation |
Minimal, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Subcut Tiss |
250 MG/KG |
5 |
53 |
53 |
18 |
1 |
Inflammation |
Mild, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Subcut Tiss |
250 MG/KG |
5 |
54 |
54 |
18 |
1 |
Inflammation |
Mild, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Subcut Tiss |
250 MG/KG |
5 |
55 |
55 |
18 |
1 |
Inflammation |
Mild, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Subcut Tiss |
500 MG/KG |
5 |
56 |
56 |
18 |
1 |
Inflammation |
Moderate, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Subcut Tiss |
500 MG/KG |
5 |
57 |
57 |
18 |
1 |
Inflammation |
Moderate, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Subcut Tiss |
500 MG/KG |
5 |
58 |
58 |
18 |
1 |
Inflammation |
Moderate, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Subcut Tiss |
500 MG/KG |
5 |
59 |
59 |
18 |
1 |
Inflammation |
Moderate, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA, Subcut Tiss |
500 MG/KG |
5 |
60 |
60 |
18 |
1 |
Inflammation |
Moderate, Chronic Active |
Terminal Sacrifice |
Respiratory System |
Lung |
Serosa |
500 MG/KG |
5 |
60 |
60 |
18 |
1 |
Fibrosis |
Minimal, Focal |
Terminal Sacrifice |